Patient preferences for treatment of advanced melanoma: impact of comorbidities-Reference-Cited by-同舟云学术

Patient preferences for treatment of advanced melanoma: impact of comorbidities

Published:2020-10-04 Issue:1 Volume:19 Page:58-70
ISSN:1610-0379
Container-title:JDDG: Journal der Deutschen Dermatologischen Gesellschaft
language:de
Short-container-title:J Deutsche Derma Gesell

Author:

Weilandt Juliane¹,Diehl Katharina²,Schaarschmidt Marthe‐Lisa³,Kiecker Felix⁴⁵,Sasama Bianca¹,Pronk Melanie⁶,Ohletz Jan⁶,Könnecke Andreas⁵,Müller Verena³⁷,Utikal Jochen³⁷,Hillen Uwe⁵,Harth Wolfgang⁶,Peitsch Wiebke K.¹

Affiliation:

1. Department of Dermatology and Phlebology Vivantes Klinikum im Friedrichshain Berlin Germany

2. Mannheim Institute of Public Health Social and Preventive Medicine Medical Faculty Mannheim Heidelberg University Mannheim Germany

3. Department of Dermatology Venereology and Allergology University Medical Center Mannheim Heidelberg University Mannheim Germany

4. Department of Dermatology Venereology und Allergology Charité University Medicine Berlin Berlin Germany

5. Department of Dermatology and Venereology Vivantes Klinikum Neukölln Berlin Germany

6. Department of Dermatology and Allergology Vivantes Klinikum Spandau Berlin Germany

7. Skin Cancer Unit German Cancer Research Center (DKFZ) Heidelberg Germany

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ddg.14293

Reference47 articles.

1. Cancer in Germany in 2015/2016. 12th edition. Berlin: Robert Koch Institute;Institute Robert Koch;Association of Population‐based Cancer Registries in Germany,2019

2. Tumour stage distribution and survival of malignant melanoma in Germany 2002–2011

3. The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987–2009: a registry-based cohort study

4. Role, extent, and impact of comorbidity on prognosis and survival in advanced metastatic melanoma: A review;Bebe FN;J Clin Aesthet Dermatol,2019

5. Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective;Journal of Cancer Research and Clinical Oncology;2024-05-14

2. Preferences of German and Swiss melanoma patients for toxicities versus melanoma recurrence during adjuvant treatment (GERMELATOX-A-trial);Journal of Cancer Research and Clinical Oncology;2023-07-05

3. Side effects, quality of life, and treatment adherence in melanoma patients undergoing systemic therapy;Die Onkologie;2023-07-05

4. Zwanzig Jahre und kein bisschen leise!;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-04

5. Onkologische Systemtherapie bis zum bitteren Ende?;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2022-12-05